SCHEMBL3266072

SCHEMBL3266072

CCCCC(=O)NCc1ccc(O)c(OC)c1

nearest known ligand 0.90

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.90
CYP1A2 P05177 2/20 0.90
CYP3A4 P08684 2/20 0.90
CYP2D6 P10635 2/20 0.90
ALDH1A1 P00352 2/20 0.90
CYP2C9 P11712 1/20 0.90
ALOX15 P16050 1/20 0.90
CYP2C19 P33261 1/20 0.90
BLM P54132 1/20 0.90
PMP22 Q01453 1/20 0.90
TRPV1 Q8NER1 9/20 0.84
MAPT P10636 2/20 0.78
MEN1 O00255 1/20 0.78
TP53 P04637 1/20 0.78
MTOR P42345 1/20 0.78
KMT2A Q03164 1/20 0.78

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15259678 0.96 HPGD (0.97) HPGDCYP1A2CYP3A4CYP2D6ALDH1A1
SCHEMBL1155582 0.95 CYP1A2 (1.00) HPGDCYP1A2CYP3A4CYP2D6ALDH1A1
SCHEMBL5088067 0.95 CYP1A2 (1.00) HPGDCYP1A2CYP3A4CYP2D6ALDH1A1
SCHEMBL5889449 0.95 CYP1A2 (1.00) HPGDCYP1A2CYP3A4CYP2D6ALDH1A1
SCHEMBL1155739 0.95 CYP1A2 (1.00) HPGDCYP1A2CYP3A4CYP2D6ALDH1A1
SCHEMBL8373082 0.95 CYP1A2 (1.00) HPGDCYP1A2CYP3A4CYP2D6ALDH1A1
SCHEMBL2400979 0.95 CYP1A2 (1.00) HPGDCYP1A2CYP3A4CYP2D6ALDH1A1
Nonivamide SCHEMBL81939 0.95 CYP1A2 (1.00) HPGDCYP1A2CYP3A4CYP2D6ALDH1A1
SCHEMBL679954 0.95 CYP1A2 (1.00) HPGDCYP1A2CYP3A4CYP2D6ALDH1A1
SCHEMBL29669968 0.95 CYP1A2 (1.00) HPGDCYP1A2CYP3A4CYP2D6ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2099316-B1 FLAVOUR MODULATING DERIVATIVE OF A CARBOXYLIC ACID AND A PURINE, PYRIMIDINE, NUCLEOSIDE OR NUCLEOTIDE GIVAUDAN SA (CH) 2017-06-21 EP disclosed
US-20130028846-A1 Flavour Modulating Derivative of a Carboxylic Acid and a Purine, Pyrimidine, Nucleoside, or Nucleotide GIVAUDAN NEDERLAND SERVICES B.V. (NL) 2013-01-31 US disclosed
US-8293215-B2 Flavour modulating derivative of a carboxylic acid and a purine, pyrimidine, nucleoside, or nucleotide GIVAUDAN NEDERLAND SERVICES B.V. (NL) 2012-10-23 US disclosed
US-20100074850-A1 Flavour Modulating Derivative of a Carboxylic Acid and a Purine, Pyrimidine, Nucleoside, or Nucleotide GIVAUDAN NEDERLAND SERVICES B.V. (NL) 2010-03-25 US disclosed
EP-2099316-A1 FLAVOUR MODULATING DERIVATIVE OF A CARBOXYLIC ACID AND A PURINE, PYRIMIDINE, NUCLEOSIDE OR NUCLEOTIDE Givaudan Nederland Services B.V. (NL) 2009-09-16 EP disclosed
WO-2008072963-A1 FLAVOUR MODULATING DERIVATIVE OF A CARBOXYLIC ACID AND A PURINE, PYRIMIDINE, NUCLEOSIDE OR NUCLEOTIDE GIVAUDAN NEDERLAND SERVICES B.V. (NL) 2008-06-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100074850-A1 Flavour Modulating Derivative of a Carboxylic Acid and a Purine, Pyrimidine, Nucleoside, or Nucleotide NUDT1, GART, UMPS HPGD 354/4885CYP1A2 1007/4885CYP3A4 1055/4885
US-20130028846-A1 Flavour Modulating Derivative of a Carboxylic Acid and a Purine, Pyrimidine, Nucleoside, or Nucleotide NUDT1, GART, UMPS HPGD 333/4885CYP1A2 1046/4885CYP3A4 1127/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.